Incaier Files IPO Prospectus: Empowering Health Through Technology

Vaccinations at your doorstep, medical consultations without leaving home, and robotic caregivers assisting in treatment... Within the ecosystem of Haier’s big health brand, Yingkang Yisheng (INKON Life), numerous sci-tech innovators may operate in different professional fields, but they all share the vision of “Ensuring Lifelong Health and Well-being for All.” Rooted here, they drive the healthcare industry forward with entrepreneurial passion, safeguarding life and health.

Behind every scientific and technological achievement lies the drive of Haier’s all-employee maker mechanism for talent. “Maximizing human value” is the core of the maker system and also the innovation gene of INKON Life, passed down from generation to generation.

Haier Biomedical, under the INKON Life umbrella, has unveiled “Deep Blue,” the world’s first IoT-enabled hydrocarbon ultra-low temperature freezer operating at -150°C, marking a milestone in ultra-low temperature technology. In March this year, 60 units of the “Deep Blue” freezers were successfully delivered to overseas markets, a development of significant importance for enhancing the global influence of China’s independent brands and promoting the advancement of the biomedical industry.

For two decades, the R&D team at Masep, a subsidiary of INKON Life, has remained steadfast in tackling two major challenges: “technical breakthroughs in Gamma Knife development” and “cobalt source supply constraints.” Currently, Masep has become the only Chinese enterprise to export large-scale radiotherapy equipment to developed countries for clinical use, and it is jointly promoting the research and development of “medical Cobalt-60” through equity investments in relevant companies. In December 2019, Chinese Gamma Knife systems were officially equipped with “Chinese cores,” completely breaking the foreign monopoly on medical cobalt sources and bringing hope of survival to numerous cancer patients.

In January this year, the Qingdao Medical and Elderly Care Health Industry Promotion Association released Qingdao’s first “Specifications for the Construction and Management of Cell Preparation Centers.” As the association’s president unit, Haier International Cell Bank, under INKON Life, led the research and development of these specifications. The implementation of these specifications will accelerate the legalization, standardization, and professionalization of the cell industry, helping Qingdao seize opportunities in the bioeconomy and promoting the clinical translation of cutting-edge international personalized cell therapy technologies, as well as the research, development, and industrial commercialization of cell-based drugs. This marks a solid step forward in the development of Qingdao’s cell industry, significantly enhancing its international competitiveness in the field of biotechnology.

Stories like this are abundant at INKON Life. As research achievements are translated into practical applications, scientific talents not only realize their personal value and aspirations but also create tangible social value. In this process, INKON Life serves as an “enabler,” providing researchers with the freedom to innovate, continuously unleashing ecosystem vitality, integrating innovative resources, and connecting various resource nodes—including research institutions and industry experts—to tackle key challenges alongside scientific talents.

As of the end of last year, INKON Life had nearly 1,000 R&D personnel, secured over 500 national patents, and received more than 80 industry honors. On its path of pioneering innovation, a steady stream of scientific research talent continues to join, drawn to INKON Life where they find a sense of belonging and a promising future.

Since joining Haier Biomedical after graduating in 2005, Gong Yi has dedicated himself to laboratory work for 13 years, collaborating with colleagues to overcome numerous challenges in ultra-low temperature refrigeration technology. It was not until the spring of 2018, when he engaged directly with end-users, that he realized: “What users need is not merely an inoculation cabinet, but zero-error vaccine administration. How can this challenge be addressed? It requires a comprehensive solution that integrates resources from multiple stakeholders.”

After three days of intense deliberation, Gong Yi resigned from his position as R&D Director and built the VaccineNet team from the ground up. After three months of relentless effort, the VaccineNet team launched a smart, end-to-end solution for vaccination services. This solution enables seamless interconnectivity among people, devices, and vaccines, achieving zero-error vaccine retrieval, instant freezing of problematic vaccines, and full traceability throughout the vaccination process. Shortly thereafter, to facilitate easier access to vaccinations for users, Gong Yi and his team innovatively introduced mobile vaccination vehicles, bringing vaccination services directly to residents’ doorsteps. Through this journey, Gong Yi successfully transformed from a researcher into an entrepreneur.

The vibrant surge of technological innovation has made the INKON Life ecosystem increasingly open and diversified. Not only research talents, but every maker has become a “creator” of innovative achievements, shining in their respective areas of expertise. Makers from INKON Life, represented by Gong Yi, are continuously meeting user needs through innovative technologies, creating greater value for individuals, users, and society.

At Sichuan Youyi Hospital, under the INKON Life umbrella, the Nursing Department has continuously practiced and iterated its approaches to enhance the care experience for oncology patients. This has led to the organic formation of specialized nursing teams grounded in professional expertise, including those focused on intravenous therapy, psychological counseling, nutritional support, pain management, and rehabilitation. By enhancing service capabilities across multiple dimensions, these teams provide patients with comprehensive, end-to-end care spanning from in-hospital treatment to home-based rehabilitation.

Mindful of discharged patients who are bedridden or have limited mobility, Yuncheng First Hospital’s Internet Hospital, under the INKON Life umbrella, has undergone a comprehensive upgrade by launching the ten most requested home-based nursing services. These include PICC line care, stoma care, insertion and replacement of gastric tubes, routine enemas, drainage tube care, and venous blood sample collection. Currently, all nursing team members providing offline appointment-based services are nationally or provincially certified specialist nurses, enabling patients to receive professional specialist nursing care in the comfort of their homes.

Furthermore, the five major scenarios of “Smart Wards, Smart Diagnosis and Treatment, Smart Weaning, Smart Settlement, and Smart Rehabilitation” implemented at Shanghai Yongci Rehabilitation Hospital, a subsidiary of INKON Life; as well as the explorations by Shanghai INKON Nursing Home and its branches, Xujing Care Center and Baihe Care Center, in the field of “IoT-based Elderly Care and Nursing Integrating Traditional Chinese and Western Medicine,” all represent the efforts of INKON professionals on their journey of scientific and technological innovation.

Behind this lies INKON Life’s people-centric innovative thinking, its user-needs-driven strategic layout, and above all, the relentless self-transcendence of every INKON professional. Countless INKON team members have centered their efforts on user needs, continuously exploring and applying innovative technological solutions to build an integrated ecosystem spanning “prevention, diagnosis, treatment, rehabilitation, and elderly care,” infusing technology with warmth and safeguarding lifelong health for every individual.